Template:Immunohistochemistry evaluation of invasive breast cancer
Immunohistochemistry
- Ki-67 index:[1]
-
Ki-67 in an invasive breast cancer: cancer nuclei are stained (brown). There is tumor cell positivity in 70% of the cells (Ki-67 labelling index = 70%).
- At least three high-power (×40 objective) fields should be selected
- At least 500 malignant invasive cells should be counted, unless a protocol clearly states reasons for fewer being acceptable.
- The invasive edge of the tumor should be scored
- If a comparisons must be made between core biopsies and sections from an excision, evaluation of the latter should be across the whole tumor.
- Only nuclear staining counts. Staining intensity of a positive nucleus is not relevant.
- HER2/neu score or status:
| Score[2] | Status[2] |
|---|---|
| 0 to 1+ | HER2 negative (not present) |
| 2+ | Borderline |
| 3+ | HER2 positive |
Notes
Main page
References
- ↑ Dowsett, M.; Nielsen, T. O.; A'Hern, R.; Bartlett, J.; Coombes, R. C.; Cuzick, J.; Ellis, M.; Henry, N. L.; et al. (2011). "Assessment of Ki67 in Breast Cancer: Recommendations from the International Ki67 in Breast Cancer Working Group ". JNCI Journal of the National Cancer Institute 103 (22): 1656–1664. doi:. ISSN 0027-8874.
- ↑ 2.0 2.1 . IHC Tests (ImmunoHistoChemistry). Breastcancer.org. Retrieved on 2019-10-04. Last modified on October 23, 2015
Image sources